A new study found that people taking a GLP-1 medication for weight loss may lower their risk for a type of vision loss called age-related macular degeneration (AMD)
There is financial incentive and inducement to overpromise before all the research is in. Elysium, co-founded in 2014 by a prominent MIT scientist to commercialize the molecule nicotinamide riboside, a type of NAD booster, highlights its exclusive licensing agreement with Harvard and the Mayo Clinic and Sinclairs role as an inventor
Detox Drip: $250 The Detox Drip supports deeper cleansing of toxins, chemicals, and heavy metals while enhancing liver function and cognitive clarity
Confounders such as sex, age, systemic hypertension, obstructive sleep apnea, hyperlipidemia and coronary artery disease were all accounted for, as were contraindications for use of semaglutide
Research by Feng (Luo et al., 2024) et al